Adage Capital Partners
NXTC icon

Adage Capital Partners’s NextCure NXTC Stock Holding History

Adage Capital Partners’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Buy
+277,202
New +$2.05M ﹤0.01% 909
2021
Q2 		– Sell
-12,500
Closed -$1.5M – 1049
2021
Q1 		$1.5M Buy
+12,500
New +$1.81M ﹤0.01% 865

Other funds holding NXTC

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
Verdad Advisers Boston, Massachusetts $104M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Adage Capital Partners's NXTC Position: Q2 2026 in Review

Adage Capital Partners opened a new position in NextCure (NXTC) in Q2 2026: 277,202 shares worth $444K. The stake represents ﹤0.01% of the portfolio and ranks #909 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in NXTC as recently as Q1 2021.

Adage Capital Partners first reported a position in NXTC in Q1 2021 and has held it in 2 quarters since. The position peaked at $1.5M in Q1 2021. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

  • Adage Capital Partners held 277,202 shares of NextCure worth $444K as of Q2 2026.
  • NextCure was a new Adage Capital Partners position in Q2 2026.
  • NextCure made up ﹤0.01% of Adage Capital Partners's portfolio in Q2 2026, its #909 holding.
  • Adage Capital Partners first reported a position in NextCure in Q1 2021 and has held it in 2 quarters since.
  • Adage Capital Partners's NextCure position peaked at $1.5M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.